Efficacy of percutaneous transluminal renal angioplasty with stent in elderly male patients with atherosclerotic renal artery stenosis

Clinical Interventions in Aging

Volumn 7, Issue , 2012, Pages 417-422

  Zhao, Jiahui ^a   Cheng, Qingli ^a   Zhang, Xiaoying ^a   Li, Meihua ^a   Liu, Sheng ^a   Wang, Xiaodan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Angioplasty; Elderly; Hypertension; Renal artery stenosis; Renal function

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ANGIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STENT; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ATHEROSCLEROSIS; BLOOD PRESSURE; DIABETES COMPLICATIONS; FLUID THERAPY; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84872334565     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S36925     Document Type: Article

References (23)

1. Kalra PA, Guo H, Kausz AT, etal. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293-301.
2. Hansen KJ, Edwards MS, Craven TE, etal. Prevalence of renovascular disease in the elderly: a population based study. J Vasc Surg. 2002;36:443-451.
3. Conlon PJ, Little MA, Pieper K, etal. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490-1497.
4. Dorros G, Jaff M, Mathiak L, etal. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
5. van Jaarsveld BC, Krijnen P, Pieterman H, etal. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-1014.
6. Burket MW, Cooper CJ, Kennedy DJ, etal. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139:64-71.
7. Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2study. J Am Coll Cardiol. 2005;46:776-783.
8. Pizzolo F, Mansueto G, Minniti S, etal. Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg. 2004;39:140-147.
9. The ASTRAL Investigators. Revascularization versus medical therapy for renal artery stenosis. N Engl J Med. 2009;361:1953-1962.
10. Wang F, Wang M, Wang HY. Survey on occurrence rate of renal arterial stenosis in patients with arteriosclerosis. Chin J Nephrol. 2005;21:139-142.
11. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Seventh annual report. (JNC VII).2003. Hypertension, 42:1206-52.
12. Levey AS, Stevens LA, Schmid CH, etal. A new equation to estimate glomerular filtration rate. Ann Intern. 2009;150:604-612.
13. [No authors listed]. Guidelines for percutaneous transluminal angioplasty. Standards and Practice Committee of the Society of Cardiovascular and Interventional Radiology. Radiology. 1990;177:619-626.
14. Tsao CR, Lee WL, Liu TJ, etal. Delicate percutaneous renal artery stenting minimizes postoperative renal injury and protects kidney in patients with severe atherosclerotic renal artery stenosis and impaired renal function. Int Heart J. 2005;46:1061-1072.
15. Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology. 2003;226:821-826.
16. Matthew SE, Matthew AC. Contemporary management of atherosclerotic renovascular disease. J Vasc Surg. 2009;5:1-14.
17. Jiang XJ, Wu HY, Zhang HM, etal. Clinical results of PTRAS in treating renovascular hypertension. Chin Circ J. 2006;2:89-92.
18. Bax L, Woittiez AJ, Kouwenberg HJ, etal. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150:840-848.
19. Wheatley K, Ives N, Gray R, etal. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-1962.
20. Mistry S, Ives N, Harding J, etal. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens. 2007;21:511-515.
21. Bax L, Mali WP, Buskens E, etal. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery: the STAR-study: rationale and study design. J Nephrol. 2003;16:807-812.
22. Lederman RJ, Mendelsohn FO, Santos R, etal. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142:314-323.
23. Zeller T, Frank U, Müller C, etal. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.